8-K: Maze Therapeutics, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-16 AccNo: 0001193125-26-424067 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se
Filed: 2026-10-16 AccNo: 0001193125-26-424067 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se